How a 67% randomization rate led to 3 months saved in a Parkinson’s trial [patient recruitment case study]
Parkinson’s disease is a disorder of the central nervous system that affects movement, with symptoms such as tremor, slow movement, stiffness, and loss of balance. Current treatments come with side effects, and there is no cure. This means research is critical to developing new and better treatments for the nearly one million people in the US living with Parkinson’s disease.
In this case study, a small pharma company hired Antidote to identify 250 phone-validated patient referrals in 12 months. We used our precision recruitment model, including thoughtful targeting, to ensure we reached people with Parkinson’s disease who would meet the difficult eligibility criteria of this trial.
Antidote developed a custom pre-screener and targeted marketing materials, and arranged paid and partner outreach to connect with potentially eligible patients. Patients engaged with marketing materials, then landed on a study-specific landing page. From there, they took the pre-screener, then had their eligibility validated via phone by Antidote’s team of Patient Liaison Managers before being sent to a site.
Based on our performance, this contract was extended three times with Antidote ultimately delivering 533 phone-validated patients and a 67% randomization rate — which saved our client three months overall.